Fundz

Real-World Data &Amp; Technology Company Om1 Closes $85 Million Financing To Make Healthcare More Measured, Precise, And Pre-Emptive

PRIVATEJul 16, 2021

Amount Raised

$85 Million

Round Type

Funding Round

BostonBiotechnologyHealth CareArtificial Intelligence

Description

OM1, a health technology company focused on real-world outcomes for chronic conditions, today announced an $85 million financing led by D1 Capital Partners, Kaiser Permanente, and Breyer Capital, with participation from existing investors, including General Catalyst (GC), Polaris Partners, Scale Venture Partners, 7wire Ventures, and Glikvest.

Quick answer

OM1 raised $85 Million in a Funding Round round, dated July 16, 2021. OM1 is based in Boston, Massachusetts, United States.

How much did OM1 raise?
OM1 raised $85 Million in a Funding Round round on July 16, 2021.
What does OM1 do?
OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and..
Where is OM1 based and how big is it?
OM1 is based in Boston, Massachusetts, United States. Fundz records about 132 employees.
Who are the decision-makers at OM1?
Fundz holds 1 contact at OM1. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at OM1, and when

A new round usually means OM1 is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OM1 raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OM1, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OM1. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OM1

Location

31 Saint James Ave, Suite 1125

Boston, Massachusetts, United States

About

OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OM1 raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for OM1's next move

See what Strategic adds

OM1 raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.